For research use only. Not for therapeutic Use.
Rentiapril is an orally active angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity[1][2].
| Catalog Number | I019281 |
| CAS Number | 80830-42-8 |
| Synonyms | (2R,4R)-2-(2-hydroxyphenyl)-3-(3-sulfanylpropanoyl)-1,3-thiazolidine-4-carboxylic acid |
| Molecular Formula | C13H15NO4S2 |
| Purity | ≥95% |
| InChI | InChI=1S/C13H15NO4S2/c15-10-4-2-1-3-8(10)12-14(11(16)5-6-19)9(7-20-12)13(17)18/h1-4,9,12,15,19H,5-7H2,(H,17,18)/t9-,12+/m0/s1 |
| InChIKey | BSHDUMDXSRLRBI-JOYOIKCWSA-N |
| SMILES | C1C(N(C(S1)C2=CC=CC=C2O)C(=O)CCS)C(=O)O |
| Reference | [1]. Cozens DD, et al. Reproductive toxicity studies of rentiapril. Arzneimittelforschung. 1987 Feb;37(2):164-9. [2]. Ideishi M, et al. Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension. Clin Ther. 1989 Jul-Aug;11(4):441-51. |
